Filed Pursuant to Rule 424(b)(5)
Registration No. 333-271113
Prospectus Supplement
(To Prospectus dated April 4, 2023)
$300,000,000
Common Stock
We have entered into a sales agreement with BofA Securities, Inc., B. Riley Securities, Inc., Barclays Capital Inc., BNP Paribas Securities Corp., Capital One Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Raymond James & Associates, Inc., RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc. and Truist Securities, Inc., or the agents, relating to the offering of shares of our common stock, $0.01 par value per share, or common stock, having an aggregate gross sales price of up to $300,000,000.
In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock offered hereby from time to time through the agents as our sales agents. Sales of shares of our common stock, if any, will be made in negotiated transactions, including block trades, or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, by means of ordinary brokers’ transactions at market prices prevailing at the time of sale, including sales made directly on the New York Stock Exchange, or NYSE, sales made to or through a market maker and sales made through other securities exchanges or electronic communications networks.
Our common stock is listed on the NYSE under the trading symbol “SAFE.” The last reported sale price of our common stock on the NYSE on April 4, 2023 was $29.20 per share.
We have elected to be taxed as a real estate investment trust, or REIT, for U.S. federal income tax purposes, commencing with our taxable year ended December 31, 1998. Shares of our common stock are, with certain exceptions, subject to a 9.8% ownership limitation to, among other things, assist us in qualifying and maintaining our qualification as a REIT. In addition, our charter contains various other restrictions on the ownership and transfer of shares of our common stock. See “Description of Capital Stock — Common Stock — Restrictions on Ownership and Transfer” in the accompanying prospectus.
No agent is required to sell any specific number or dollar amount of shares of our common stock, but each agent has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, as our sales agent, and subject to the terms and conditions of the sales agreement, to sell shares of our common stock on our behalf, on mutually agreed terms between the agent and us. Shares of our common stock offered and sold through the agents, as our sales agents, pursuant to this prospectus supplement and the accompanying prospectus, will be offered and sold through only one agent on any given day.
Each agent will receive from us a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of all shares of our common stock sold through it as sales agent under the sales agreement.
Under the terms of the sales agreement, we may also sell shares of our common stock to one or more of the agents, as principal, at a price per share to be agreed upon at the time of sale. If we sell shares of our common stock to one or more of the agents as principal, we will enter into a separate terms agreement with such agent or agents, as the case may be, and we will describe the terms of the offering of those shares of our common stock in a separate prospectus supplement. In any such sale to an agent as principal, we may agree to pay the applicable agent an underwriting discount or commission that may exceed 2.0% of the gross sales price per share sold to such agent, as principal.
In connection with the sale of shares of our common stock on our behalf, each agent may, and in connection with sales of shares of our common stock purchased by an agent as principal will, be deemed to be an “underwriter” within the meaning of the Securities Act, and the fees paid to such agent may, or will, as applicable, be deemed to be underwriting compensation.
Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page S-4 of this prospectus supplement and the information set forth in our filings under the Securities Exchange Act of 1934, as amended, that are incorporated herein by reference. Neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
BofA Securities B. Riley Securities Barclays BNP PARIBAS
Capital One SecuritiesGoldman Sachs & Co. LLCJ.P. Morgan
MizuhoMorgan StanleyRaymond James
RBC Capital Markets SMBC Nikko Truist Securities
The date of this prospectus supplement is April 5, 2023